• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘内给药用于成人疼痛和痉挛的管理:英国疼痛学会最佳临床实践建议

Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.

作者信息

Eldabe Sam, Duarte Rui, Thomson Simon, Bojanic Stana, Farquhar-Smith Paul, Bagchi Somnath, Farquhar Lis, Wetherill Bill, Copley Sue

机构信息

Department of Pain Medicine, The James Cook University Hospital, Middlesbrough, UK.

Liverpool Reviews and Implementation Group, Department of Health Data Science, University of Liverpool, Liverpool, UK.

出版信息

Br J Pain. 2024 Sep 7:20494637241280356. doi: 10.1177/20494637241280356.

DOI:10.1177/20494637241280356
PMID:39552923
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11561936/
Abstract

The British Pain Society updated their recommendations on intrathecal drug delivery (ITDD) for the management of pain and spasticity in adults. The recommendations are primarily evidence based but where necessary comprise the consensus opinion of the working group. The recommendations are accompanied by information for patients and their carers, intended to inform and support patients in their decision making. The updated guidance includes recent evidence base of ITDD use in pain and spasticity, address the issues of drug pump compatibility following the latest manufacturer and Medicines and Healthcare products Regulatory Agency (MHRA) recommendations as well as provide an update on the indications and complication management particularly endocrine complications and intrathecal granuloma formation.

摘要

英国疼痛协会更新了关于鞘内药物递送(ITDD)用于成人疼痛和痉挛管理的建议。这些建议主要基于证据,但在必要时包含了工作组的共识意见。建议还附带了针对患者及其护理人员的信息,旨在为患者的决策提供信息和支持。更新后的指南包括ITDD用于疼痛和痉挛的最新证据基础,根据最新的制造商和药品及医疗产品监管局(MHRA)建议解决药物泵兼容性问题,并提供关于适应症和并发症管理的最新信息,特别是内分泌并发症和鞘内肉芽肿形成。

相似文献

1
Intrathecal drug delivery for the management of pain and spasticity in adults: British Pain Society's recommendations for best clinical practice.鞘内给药用于成人疼痛和痉挛的管理:英国疼痛学会最佳临床实践建议
Br J Pain. 2024 Sep 7:20494637241280356. doi: 10.1177/20494637241280356.
2
Intrathecal drug delivery for the management of pain and spasticity in adults: an executive summary of the British Pain Society's recommendations for best clinical practice.成人疼痛和痉挛管理的鞘内药物递送:英国疼痛学会最佳临床实践建议的执行摘要
Br J Pain. 2016 May;10(2):67-9. doi: 10.1177/2049463715587747. Epub 2015 May 27.
3
Intrathecal Drug Delivery Systems for the Management of Chronic Noncancer Pain: A Systematic Review of Economic Evaluations.鞘内药物输送系统治疗慢性非癌性疼痛的经济学评价系统综述。
Pain Pract. 2018 Jun;18(5):666-686. doi: 10.1111/papr.12650. Epub 2017 Dec 1.
4
Spinal cord stimulation for the management of pain: Recommendations for best clinical practice.脊髓刺激治疗疼痛管理:最佳临床实践建议。
S Afr Med J. 2013 Mar 26;103(6 Pt 2):423-30. doi: 10.7196/samj.6323.
5
The Polyanalgesic Consensus Conference (PACC): Recommendations on Intrathecal Drug Infusion Systems Best Practices and Guidelines.多模式镇痛共识会议(PACC):关于鞘内药物输注系统最佳实践和指南的建议。
Neuromodulation. 2017 Feb;20(2):96-132. doi: 10.1111/ner.12538. Epub 2017 Jan 2.
6
The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.多模式镇痛共识会议(PACC):鞘内给药建议:提高安全性和降低风险的指南
Neuromodulation. 2017 Feb;20(2):155-176. doi: 10.1111/ner.12579. Epub 2017 Jan 2.
7
The Polyanalgesic Consensus Conference (PACC)®: Updates on Clinical Pharmacology and Comorbidity Management in Intrathecal Drug Delivery for Cancer Pain.多模式镇痛共识会议(PACC)®:癌症疼痛鞘内药物输注的临床药理学与合并症管理的最新进展
Neuromodulation. 2024 Sep 20. doi: 10.1016/j.neurom.2024.08.006.
8
The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain.多模式镇痛共识会议(PACC)®:鞘内药物输注治疗慢性非癌痛的安全性和治疗优化指南。
Neuromodulation. 2024 Oct;27(7):1107-1139. doi: 10.1016/j.neurom.2024.03.003. Epub 2024 May 16.
9
Best practices for intrathecal drug delivery for pain.鞘内药物输注治疗疼痛的最佳实践
Neuromodulation. 2014 Jun;17(4):354-72; discussion 372. doi: 10.1111/ner.12146. Epub 2014 Jan 21.
10
Polyanalgesic Consensus Conference--2012: recommendations on trialing for intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel.多模式镇痛共识会议-2012:椎管内(脊髓内)药物输注试验的建议:跨学科专家小组的报告。
Neuromodulation. 2012 Sep-Oct;15(5):420-35; discussion 435. doi: 10.1111/j.1525-1403.2012.00450.x. Epub 2012 Apr 11.

引用本文的文献

1
Wet Tap-Induced Spinal Cord Stimulator Trial Failure in Failed Back Surgery Syndrome: A Case Report Highlighting Intrathecal Drug Delivery for Treatment-Resistant Pain.腰椎手术失败综合征中湿式穿刺致脊髓刺激器试验失败:一例报告,强调鞘内药物递送治疗顽固性疼痛
Cureus. 2025 Jun 11;17(6):e85793. doi: 10.7759/cureus.85793. eCollection 2025 Jun.
2
Case Report: Lateral C1-C2 puncture for intrathecal baclofen therapy: an alternative effective and safe approach after spinal cord injury.病例报告:用于鞘内注射巴氯芬治疗的C1-C2外侧穿刺:脊髓损伤后一种有效且安全的替代方法。
Front Pain Res (Lausanne). 2025 Jun 10;6:1571716. doi: 10.3389/fpain.2025.1571716. eCollection 2025.

本文引用的文献

1
The Polyanalgesic Consensus Conference (PACC)®: Intrathecal Drug Delivery Guidance on Safety and Therapy Optimization When Treating Chronic Noncancer Pain.多模式镇痛共识会议(PACC)®:鞘内药物输注治疗慢性非癌痛的安全性和治疗优化指南。
Neuromodulation. 2024 Oct;27(7):1107-1139. doi: 10.1016/j.neurom.2024.03.003. Epub 2024 May 16.
2
Intrathecal Drug Delivery Systems for Cancer Pain: A Health Technology Assessment.鞘内药物输送系统治疗癌症疼痛:一项卫生技术评估。
Ont Health Technol Assess Ser. 2024 Jan 11;24(2):1-162. eCollection 2024.
3
A Clinical Evaluation of the Accuracy of an Intrathecal Drug Delivery Device.鞘内药物输送装置准确性的临床评估。
Neuromodulation. 2023 Aug;26(6):1240-1246. doi: 10.1016/j.neurom.2022.10.052. Epub 2022 Dec 5.
4
A post-market, randomized, controlled, prospective study evaluating intrathecal pain medication versus conventional medical management in the non-cancer, refractory, chronic pain population (PROSPER).一项针对非癌症、难治性慢性疼痛人群的上市后、随机、对照、前瞻性研究,评估鞘内疼痛药物与常规医学管理的疗效(PROSPER)。
Expert Rev Med Devices. 2022 Nov;19(11):895-904. doi: 10.1080/17434440.2022.2152673. Epub 2022 Dec 1.
5
Ziconotide for the Management of Cancer Pain: A Budget Impact Analysis.唑尼沙胺治疗癌症疼痛的管理:预算影响分析。
Neuromodulation. 2023 Aug;26(6):1226-1232. doi: 10.1016/j.neurom.2022.08.458. Epub 2022 Oct 4.
6
Stability of Morphine Sulfate-Clonidine and Sufentanil-Clonidine Mixtures.硫酸吗啡-可乐定和舒芬太尼-可乐定混合物的稳定性。
Neuromodulation. 2023 Aug;26(6):1195-1207. doi: 10.1016/j.neurom.2022.07.008. Epub 2022 Aug 26.
7
Rationale and Recent Advances in Targeted Drug Delivery for Cancer Pain: Is It Time to Change the Paradigm?癌症疼痛的靶向药物递送的原理和最新进展:是否是时候改变范式了?
Pain Physician. 2022 May;25(3):E414-E425.
8
Effectiveness and Safety of Intrathecal Drug Delivery Systems for the Management of Cancer Pain: A Systematic Review and Meta-Analysis.鞘内药物输注系统治疗癌症疼痛的有效性和安全性:系统评价和荟萃分析。
Neuromodulation. 2023 Aug;26(6):1126-1141. doi: 10.1016/j.neurom.2022.03.003. Epub 2022 Apr 11.
9
Physicochemical Stability Study of the Morphine-Ropivacaine-Ziconotide Association in Implantable Pumps for Intrathecal Administration.鞘内给药植入式输液泵中吗啡-罗哌卡因-齐考诺肽联合制剂的理化稳定性研究。
Neuromodulation. 2023 Aug;26(6):1179-1194. doi: 10.1016/j.neurom.2021.10.002. Epub 2021 Dec 18.
10
Management of Cancer-Related Pain With Intrathecal Drug Delivery: A Systematic Review and Meta-Analysis of Clinical Studies.鞘内药物输送治疗癌痛的管理:临床研究的系统评价和荟萃分析。
Neuromodulation. 2023 Aug;26(6):1142-1152. doi: 10.1016/j.neurom.2021.12.004. Epub 2022 Jan 21.